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Abstract1
Short-chain fatty acids play crucial roles in a range of physiological functions. However, the effects of 2
short-chain fatty acids on brown adipose tissue have not been fully investigated. We examined the role of 3
acetate, a short-chain fatty acid formed by fermentation in the gut, in the regulation of brown adipocyte 4
metabolism. Our results show that acetate up-regulates AP2, PGC-ĮDQG8&3H[SUHVVLRQ and affects 5
the morphological changes of brown adipocytes during adipogenesis. Moreover, an increase in 6
mitochondrial biogenesis was observed after acetate treatment. Acetate also elicited the activation of ERK 7
and CREB, and these responses were sensitive to G(i/o)-W\SH*SURWHLQLQDFWLYDWRU*ȕȖ-subunit inhibitor, 8
PLC inhibitor, PKC inhibitor and MEK inhibitor, indicating a role for the *LRȕȖ3/&3.&0(.9
signalling pathway in these responses. These effects of acetate were mimicked by treatment with 4-10
CMTB, a synthetic GPR43 agonist, and were impaired in GPR43 knock-down cells. Taken together, our 11
results indicate that acetate may have important physiological roles in brown adipocytes through 12
activation of GPR43. 13
14
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Introduction 1
Short-chain fatty acids are a sub-group of fatty acids including formic acid, acetic acid, propionic acid, 2
isobutyric acid, butyric acid, isovaleric acid and valeric acid. Acetate, propionate and butyrate are the 3
three major short-chain fatty acids, which are mainly formed in the gastrointestinal tract via colonic 4
bacteria fermentation of carbohydrates, especially resistant starches and dietary fibre (1). Following 5
production in the gastrointestinal tract, short-chain fatty acids, especially acetate, may enter the 6
circulation, be metabolized by peripheral tissues and directly affect energy homeostasis and metabolism. 7
Given that it is the most abundant short-chain fatty acid produced in the colon, and that it partially avoids 8
hepatic clearance, acetate can reach 150 μM concentrations in the peripheral circulation (2-7). Previous 9
reports in humans show that, depending on the time of the day, the fasting/eating pattern and the glucose 10
tolerance status of the individual, the circulating concentration of acetate could reach 100-150 μM with 11
higher levels in arterial compared to venous blood (2-7). Circulating propionate and butyrate are detected 12
in significantly lower levels (6), indicating that acetate mediates most of the short-chain fatty acids 13
induced effects in peripheral tissues. Growing evidence indicates that short-chain fatty acids play 14
important roles in a range of physiological functions, including neutrophil-driven inflammation (8), GLP-15
1 and PYY secretion (9,10), lipolysis and adipogenesis of white adipose tissue (11,12), and de novo16
synthesis of lipids and glucose (13).  17
18
Brown adipose tissue, also referred to as BAT or brown fat, is another type of adipose tissue primarily 19
found in rodents and human infants. For a long time, BAT was perceived to quickly diminish after birth 20
in humans; however, recent molecular and histological evidence have established that BAT remains 21
present in adult humans (14). Subsequently, BAT has attracted attention as a novel target for the treatment 22
of obesity and other obesity-related metabolic diseases due to its ability to generate heat by burning 23
calories. Adipogenesis constitutes the process of cell differentiation by which pre-adipocytes become 24
adipocytes. To date, it has been reported that adipogenesis of BAT is highly controlled by several 25
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WUDQVFULSWLRQ IDFWRUV VXFK DV 33$5Ȗ DQG &(%3V $ VHW RI FR-activators also regulates this process 1
through their interaction with transcription factors [e.g. 33$5ȖFRDFWLYDWRU-Į 3*&-Į LQWHUDFWVZLWK2
the transcription receptor PPAR-Ȗ DQG UHJXODWHV WKHJHQHV LQYROYHG LQ DGLSRJHQHVLV RI%$7@2IQRWH3
PGC-ĮLVKLJKO\H[SUHVVHGLQEURZQEXWQRWLQZKLWHDGLSRF\WHV)XUWKHUPRUHFROGH[SRVXUHRUFKDQJHV4
in nutritional status can dramatically up-regulate PGC-Į H[pression in BAT and skeletal muscle. 5
Moreover, ectopically expressing PGC-ĮLQZKLWHDGLSRF\WHVDOVRLQGXFHVµEURZQLQJ¶RIWKHLUSKHQRW\SH6
indicating that PGC-ĮSOD\VDQLPSRUWDQWUROHLQWKHFRQWURORIEURZQDGLSRF\WHGLIIHUHQWLDWLRQ)LQDOO\7
PGC-ĮZas also found to induce mitochondrial biogenesis, likely through the co-activation of a non-8
nuclear hormone receptor transcription factor, nuclear respiratory factor-1 (NRF-1), in brown adipocytes 9
(15). ,QWHUHVWLQJO\ GDWD IURP FOLQLFDO WULDOV KDYH VXJJHVWHG WKDW LQFUHDVHG 33$5Ȗ DFWLYLW\ E\10
thiazolidinediones (TZDs) also stimulates substantial adipogenesis in addition to reducing hyperglycemia 11
in type 2 diabetic patients (16,17). Therefore, increasing the amount and/or activity of PGC-Į LV DOVR12
considered a potential useful pharmacologic strategy for the treatment of obesity-related diseases. 13
14
G protein-coupled receptors (GPCRs) constitute a family of seven transmembrane receptors. GPCRs play 15
an important role in various signalling pathways by transducing a spectrum of extracellular signals  to 16
heterotrimeric G proteins, which further transduce these to appropriate downstream effectors in a 17
signalling cascade (18). G-protein-coupled receptor 43 (GPR43), also called free fatty acid receptor 2 18
(FFA2/FFAR2), was deorphanized as a GPCR recognizing short-chain fatty acids, i.e. acetate and 19
propionate, simultaneously by three independent groups (19-21). GPR43 reportedly couples to either Gi/o 20
or Gq signalling pathways (19) and is highly expressed in immune cells and regulates inflammatory 21
responses (8,22,23). GPR43 has also been reported to be expressed in adipose tissue. Previous data have 22
demonstrated that activation of GPR43 promotes white adipocyte differentiation, leptin secretion in L-23
cells and inhibition of lipolysis in white adipose tissue (11), suggesting that short-chain fatty acids may 24
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exert most, if not all, of their metabolic effects via GPR43 in white adipose tissue. However, there is little 1
research on the role of short-chain fatty acids and GPR43 in BAT. 2
3
With the aforementioned in mind, we examined the effects of acetate in the regulation of brown adipocyte 4
adipogenesis.  5
6
Materials and Methods 7
Reagents and Antibodies 8
Insulin, dexamethasone (Dex), isobutylmethylxanthine (IBMX), triiodothyronine (T3), and isopropanol 9
were obtained from Sigma-Aldrich (Gillingham, UK). 4-chloro-Į-(1-methylethyl)-N-2-10
thiazolylbenzeneacetamide (4-CMBT), U0126, U73122, pertussis toxin (PTX), and gallein were 11
purchased from Tocris bioscience (Bristol, UK). The antibodies used in this study are listed in Table.1.  12
Animals 13
Male C57BL/6J (4 weeks old) mice were purchased from Dakewe Biotech Co., Ltd (Beijing, China). 14
After a 2-week quarantine, the C57BL/6J mice were fed normal diet/chow until 12 weeks of age before 15
tissue harvest. For acetate administration, 6-week-old mice were treated with sodium acetate (150 mM) in 16
drinking water for 6 weeks (n = 5 for control, n = 5 for acetate administration). All of the mice were 17
housed in the animal facility with a 12-h light/dark cycle and constant temperature (22±24°C). The mice 18
had free access to water and diet. All procedures were approved by Jining Medical University and met the 19
standards of the Guide for the Care and Use of Laboratory Animals issued by the Ministry of Science and 20
7HFKQRORJ\RIWKH3HRSOH¶V5HSXEOLFRI&KLQa in 2006.  21
Cell Isolation and Culture 22
The immortalized brown adipocyte cells line (IM-BAT) was provided by Dr Mark Christian (University 23
of Warwick). Briefly, as previously described (24), primary cultures of brown adipocytes were generated 24
by first digesting the interscapular BAT from male C57BL/6 mice with Tissue Dissociation Buffer 25
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(DMEM/F12 medium containing collagenase (10 mg/ml) and DNase (10 mg/ml)) and pelleting the 1
stromal vascular fraction (SVF) by centrifugation at 170×g for 10 min. Preadipocytes were purified by 2
collecting the cells that passed through 100 μM of mesh. Next, brown preadipocytes were selected by 3
collecting the cells that passed through 70 μM of mesh and were cultured in DMEM/F12 medium 4
containing 10% FBS and 1% antibiotic-antimycotic for 2 days before being immortalized by retroviral-5
mediated expression of temperature-sensitive SV40 large T antigen H-2kb-tsA58. Cells were continually 6
cultuUHGDWÛ&DQGVHOHFWHGZLWK*PJPOIRUZHHNVDQGPDLQWDLQHGLQJPORI*7
Cells were differentiated by treating cells with differentiation medium I (DMEM/F12 containing 3-8
isobutyl-1-methylxanthine (IBMX, 500 μM), dexamethasone (250 nM)LQVXOLQQ0¶-triiodo-9
l-thyronine (T3, 1 nM) and 10% FBS) for 48 h, followed by feeding cells with differentiation medium II 10
(DMEM/F12 containing insulin (170 nM), T3 (1 nM) and 10% fetal bovine serum) every 2 days. To test 11
the effects of acetate or 4-CMTB, replicate wells were incubated with acetate (10 mM) or 4-CMTB (10 12
μM), in combination with differentiation medium II in parallel. Differentiation was completed till clear 13
lipid droplets could be seen under microscopy. All experiments were performed between passages 12 and 14
22.15
Oil Red O staining 16
Lipid accumulation of differentiated adipocytes was visualized and determined by quantitative Oil red O 17
staining kit (Millipore ECM950, Billerica, USA). Briefly, culture plates were washed in PBS, and ¿xed in 18
3.7% formaldehyde for 15 min, followed by staining with Oil Red O solution for 15 min. After staining, 19
plates were washed twice with water and photographed. Oil red O was eluted using Dye Extraction 20
Solution (100% isopropanol), and absorbance at 490 nm was measured. 21
Real time analysis using the xCELLigence system 22
The xCELLigence RTCA DP system (ACEA, San Diego, USA) ZDV LQLWLDOL]HG DV SHUPDQXIDFWXUHU¶V23
instructions prior to measurements. E-plate was filled with basal medium (100 μl/well) and equilibrated at 24
room temperature for 30 min. The E-plate was placed back into the DP station cradle (housed in a 25
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KXPLGLILHGLQFXEDWRUDWÛ&ZLWKD&22 atmosphere) to establish the background reading. IM-BAT 1
cells were plated into E-plate at 5×104 cells per well in 100 μl aliquots. The E-plate was equilibrated at 2
room temperature for 30 min before moved back into the DP station cradle. Cells were treated with 3
differential medium I as described above for 2 days, followed by incubation with differential medium II 4
only or with acetate/4-CMTB until day 7 post-induction. The xCELLigence system monitors the electrical 5
impedance of gold sensing electrode underneath the cultured cell layer and calculates arbitrary cell index 6
(CI) units as follows: CI = (Zi-Z0) / 15, in which Zi represents the electrical impedance at given time 7
points and Z0 constitutes the background electrical impedance. The differentiation of IM-BAT cells in E-8
plate were also confirmed by optical microscope observation. 9
Cell viability assay 10
The MTS assay was performed in a time-course manner to determine the number of viable cells in culture. 11
IM-BAT cells were seeded in 96-well plates at a density of 5×104 cells/well and treated with 12
differentiation medium I for 2 days after cells reached confluence. Then cells were incubated with 13
differentiation medium II for another 5 days. The CellTiter 96®AQueous One Solution Reagent (Promega, 14
Fitchburg, USA) was added into each well and the absorbance was measured at 490 nm in a plate reader 15
to determine the formazan concentration, which is proportional to the number of living cells in culture. 16
Quantitative real-time PCR 17
7RWDO 51$ ZDV LVRODWHG XVLQJ *HQ(OXWH 0DPPDOLDQ 7RWDO 51$ 0LQLSUHS .LW 6LJPD-Aldrich, 18
Gillingham, UK). To degrade genomic DNA, a DNase digestion was performed with Precision DNase 19
kits (Primerdesign, Southampton, UK). Up to ȝJRIWRWDO51$ZDVUHYHUVHWUDQVFULEHGLQȝ/XVLQJ20
the Precision nanoScript Reverse Transcription kits (Primerdesign, Southampton, UK). A portion of 21
UHYHUVH WUDQVFULSWLRQ UHDFWLRQ SURGXFWZDV DPSOL¿HG WR D WRWDO YROXPHRI ȝ/ FRQWDLQLQJ Q0RI22
each primer and 1× SYBR green PCR master mix (Applied Biosystems, Waltham, USA). Analysis of 23
gene expression was carried out in ABI 7500 Fast Real-Time PCR System with initial denaturation at 24
95 °C for 20 s, followed by 40 PCR cycles, each cycle consisting of 95 °C for 3 s and 60 °C for 30 s, and 25
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6<%5 JUHHQ ÀXRUHVFHQFH HPLVVLRQV ZHUH PRQLWRUHG DIWHU HDFK F\FOH P51$ H[SUHVVLRQ OHYHOV ZHUH1
calculated relative to the expression of the housekeeping gene 60S ribosomal protein L19 (RPL19). 2
$PSOL¿FDWLRQRIVSHFL¿F WUDQVFULSWVZDVFRQ¿UPHGE\WKHPHOWLQJ-FXUYHSUR¿OHVFRROLQJWKHVDPSOHWR3
&DQGKHDWLQJVORZO\WR&ZLWKPHDVXUHPHQWRIÀXRUHVFHQFHDWWKHHQGRIHDFK3&54
Measurement of Mitochondrial DNA by Quantitative Real-time PCR 5
DNA was isolated from differentiated IM-BAT cells using QIAamp DNA Mini Kit (QIAgen, Hilden, 6
Germany). The mitochondrial DNA level was measured with primers targeted for mouse mitochondrial 7
D-Loop with 1× SYBR green PCR master mix (Applied Biosystems, Waltham, USA) in ABI 7500 Fast 8
Real-Time PCR System as described above. The mitochondrial DNA levels were normalized against the 9
nuclear DNA level measured with 18S primers using the comparative CT method. 10
Measurement of Mitochondrial Mass by Flow Cytometry 11
Preadipocytes were grown tR FRQÀXHQFH DQG GLIIHUHQWLDWHG DV GHVFULEHG DERYH for 7 days. The fully 12
differentiated cells were incubated with 50 nM CytoPainter MitoNIR Indicator Reagent (abcam, 13
Cambridge, UK) in DMEM/F12 medium for 30 min at 37 °C. Cells were then washed with PBS, 14
trypsinised, centrifuged, and resuspended in DMEM/F12 medium. Cells were analysed by Beckman 15
&RXOWHU)& IORZ F\WRPHWHUV DQG&\WR3DLQWHU0LWR1,5 ,QGLFDWRU5HDJHQWÀXRUHVFHQW LQWHQVLW\ZDV16
measured in FL4 channel.17
XF24 Bioenergetic Assay 18
The oxygen consumption rate (OCR) measurements were performed by the Seahorse XF24 analyzer 19
(Seahorse Bioscience, Copenhagen, Denmark). After the baseline measurement, testing agent (a-20
oligomycin; b-FCCP; c-antimycin A & rotenone) prepared in assay medium was then injected into each 21
well to reach the desired final concentration. The XF24 protocol consists of three measurements of OCR 22
(1 measurement/ 2 min); injection of oligomycin, and three measurements of OCR (1 measurement/ 2 23
min); injection of FCCP, and five measurements of OCR (1 measurement/ 2 min); injection of antimycin 24
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& rotenone, and three measurements of OCR (1 measurement/ 2 min). The protein content of IM-BAT 1
was measured after the XF24 bioenergetic assay and used for normalization. 2
Western blot 3
For western blot analyses, cells were lysed in RIPA buffer in the presence of phosphatase and protease 4
inhibitors. The lysates were centrifuged at 14,000 g for 10 min at 4 Û&DQGWKHVXSHUQDWDQWIUDFWLRQVZHUH5
used for collection. Samples containing equal amounts of protein were resolved in SDS-PAGE and then 6
transferred onto Amersham Hybond ECL membrane. The membranes were blocked in 5% skimmed milk 7
for 1h at room temperaturHDQGSUREHGZLWKVSHFLILFDQWLERGLHVRYHUQLJKWDWÛ&+RUVHUDGLVKSHUR[LGDVH8
conjugated anti-rabbit or anti-mouse secondary antibodies (Sigma-Aldrich, Gillingham, UK) and ECL 9
Western Blotting Substrate (Pierce, Waltham, USA) were used to visualize specific protein bands. ECL 10
results were captured by G:BOX Chemi XX6 system and quantitated using GeneTools software.  11
Immunohistochemistry staining 12
Brown adipose tissue of adult male c57bl/6 mice was immediately removed after sacrifice, and fixed in 13
10% buffered formalin. After fixation tissues were dehydrated in graded alcohol and embedded in 14
paraffin. Embedding of tissues was performed by a paraffin dispenser DP 500 (Bio-Optica, Milano, Italy). 15
The two-stage immunoperoxidase method was applied with ImmunoCruz rabbit ABC staining system 16
(Santa Cruz, Dallas, USA). Briefly, paraffin-embedded adipose tissue was cut into 3 μm thick tissue 17
sections using a rotary microtome Lecia RM2235 (Leica Microsystems, Milton Keynes, UK), which were 18
deparaffinised and re-hydrated. Heat-induced antigen retrieval was performed prior to staining. In order to 19
inhibit endogenous peroxidase activity slides were incubated in 3% solution of hydrogen peroxide for 10 20
minutes. Subsequently, non-specific antibody binding sites were blocked by incubation in goat serum for 21
30 minutes. The sections were incubated with the primary antibody (Polyclonal anti-GPR43 (Santa Cruz, 22
Dallas, USADQWLERG\GLOXWLRQRYHUQLJKWDWÛ&6XEVHTXHQWO\WKHVHFWLRQVZHUHZDVKHGLQ3%623
(5 x 3 min) and incubated with the secondary (peroxidase-conjugated) antibody for 60 min at room 24
temperature. Peroxidase activity was detected using the DAB technique (Liquid DAB substrate-25
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chromogen system). Nuclei were counterstained with haematoxylin. Control sections were similarly 1
treated with omission of the primary antibody. 2
Phospho-kinase Proteome Profiling Assay 3
IM-BAT cells were differentiated and treated with or without acetate (10 mM) for 10 min. Cell lysates 4
were prepared as described above and applied to phospho-kinase array following the manufacturer's 5
instructions (R&D Systems). The phospho-kinase array results were developed by G:BOX Chemi XX6 6
system (Sysgene) and quantitated using GeneTools software (Sysgene).  7
Knockdown of GPR43 in IM-BAT cells 8
For establishing a knockdown of GPR43, immortalized IM-BAT cells were transfected with pLKO.1-9
puro non-mammalian control, or pLKO.1 encoding shRNAs targeting GPR43 (clone IDs 10
TRCN0000027541, TRCN0000027552, TRCN0000027562, TRCN0000027581) using TransIT-2020 11
reagent from Mirus Bio LLC (Madison, USA) IROORZLQJ WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV K SRVW12
transfection, transfected cells were selected by adding 6 μg/ml puromycin. Each shRNA-encoding vector 13
was transfected in triplicate wells. Cells were differentiated for 7 days. After harvesting the cells in Qiazol, 14
the mRNA was isolated for real-time PCR analysis. Relative changes of GPR43 expression compared to 15
the pLKO.1 control were normalized to the expression of RPL19 and quantified using the 2-ǻǻ&W method. 16
Statistical analysis 17
Results are presented as the mean ± S.E.M of at least triplicate samples in each experimental group; 18
experiments were replicated to ensure consistency. Statistical significance of difference was determined 19
XVLQJ VWXGHQW¶V t test when comparing 2 groups or one-way ANOVA followed by post-KRF 7XNH\¶V20
multiple comparison test when comparing more than 3 groups. Values were considered to be statistically 21
significant if their P value was less than 0.05. Statistical analyses were performed in GraphPad Prism 6 22
(GraphPad Software Inc., San Diego, CA). 23
24
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Results1
GPR43 is expressed in brown adipose tissue and immortalized brown adipocytes 2
GPR41 and GPR43 have been de-orphaned as short-chain fatty acids receptors. To test the hypothesis that 3
GPR41 and/or GPR43 mediate the regulatory effects of acetate, real-time PCR analysis was performed on 4
BAT to measure mRNA expression levels of GPR41 and GPR43. Our results demonstrated that GPR43 5
mRNA expression reached a clearly detectable level in BAT. The significant decrease of amplification 6
products in minus-reverse transcriptase (-RT) controls confirmed that the PCR amplification is mostly 7
attributable to the presence of GPR43 cDNA (Fig.1A). To clarify that GPR43 was expressed in brown 8
adipocytes instead of stromal vascular fraction, isolated brown adipocytes were also used to analyse the 9
mRNA expression of GPR43. The mRNA transcription was quantified in immortalized brown adipocytes 10
during the course of adipose differentiation until 9 days induction of differentiation (Fig.1B). Our western 11
blot results also show that GPR43 expression was scarcely detected in pre-adipocytes (Day 0) but 12
significantly increased after differentiation induction (Fig.1C). We were unable to detect any GPR41 13
expression which is in agreement with previous studies (25). Immunohistochemical staining was also 14
used to demonstrate the existence of GPR43 in brown adipose tissue. As shown in Fig.1D, 15
immunoperoxidase staining of formalin-fixed, paraffin-embedded mice brown adipose tissue using anti-16
GPR43 antibody shows membrane and cytoplasmic staining, while in the no primary antibody control, 17
only negligible staining could be found.  18
Activation of GPR43 during differentiation of IM-BAT increases PGC-ĮDQG8&3H[SUHVVLRQ19
In order to examine the effects of acetate on differentiating brown adipocytes, IM-BAT cells were treated 20
with or without acetate (10 mM) throughout the course of the differentiation process from day 2 until day 21
7 post-induction, at which time the hypertrophic brown adipocytes filled with plenty of lipid droplets 22
(Supplementary Fig.1). Lipid accumulation in differentiated brown adipocytes was measured using Oil 23
red O staining kit. As shown in Fig.2A, acetate increased Oil red O staining of IM-BAT cells after 24
differentiation relative to normally-differentiated control cells, indicating acetate as a positive modulator 25
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of brown adipocyte development. Furthermore, the expression of several adipogenesis-related and 1
thermogenesis-related genes was also examined. As shown in Fig.2B, acetate treatment during brown 2
adipocyte differentiation (from day 2 VLJQLILFDQWO\ LQFUHDVHG WKHP51$ H[SUHVVLRQ OHYHOV RI 33$5Ȗ3
AP2, PGC-Į DQG 8&3 ,Q DGGLWLRQ ZH DOVR WUHDWHG ,0-BAT cells with 4-CMTB during the 4
differentiation, a selective agonist for GPR43 (26). As shown in Fig.2C, 4-CMTB treatment also 5
increased the expression of AP2, PGC-Į DQG 8&3, ZKLOVW WKH 33$5Ȗ H[SUHVVLRQ DOVR VKRZHG DQ6
increasing trend. The mRNA expression of BMP7 and PRDM16 did not show any significant changes 7
with either acetate or 4-CMTB treatments. Protein expression of PGC-ĮDQG8CP1 was also tested after 8
acetate treatment. Our results demonstrated that the protein levels of PGC-ĮDQG8&3H[KLELWHGa9
fold and ~2.3 fold increases, respectively, in acetate treated cells compared to normally-differentiated 10
cells (Fig.2D). 4-CMTB treatment also showed an increase of PGC-Į DQG 8&3 protein expression 11
(Fig.2E). Concentration-dependent effects of acetate treatment on PGC-Į DQG 8&3 GXULQJ EURZQ12
adipogenesis were also investigated in immortalized brown adipocytes. As shown in Supplementary Fig.2, 13
compared to the effects of 10 mM acetate treatment, acetate at 1mM also induced a pronounced increase 14
of PGC-ĮDQG8&3, while the lower concentration of acetate induced a relatively weaker response on 15
PGC-Į and UCP1 expression (Supplementary Fig.2). Overall these findings suggest that activation of 16
GPR43 during IM-BAT differentiation augments the expression of key adipogenesis markers, such as 17
AP2, and brown adipocyte markers, i.e. PGC-ĮDQG8&3 Moreover, we also examined the effects of 18
acetate on the expression of these two thermogenesis-related genes (PGC-ĮDQG8&3LQBAT in vivo.19
These results demonstrated a significant increase in PGC-Į (p=0.016), while the increase in UCP1 20
expression just failed significance (p=0.076; Fig.2F). Furthermore, acute acetate treatment (6h) on 21
differentiated IM-BAT cells also significantly increased PGC-Į (p=0.013) and UCP1 transcription 22
(p=0.028; Fig.2G). 23
Activation of GPR43 during differentiation of IM-BAT affects the morphological shift of brown 24
adipocytes during adipogenesis 25
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The xCELLigence system monitors the electrical impedance of gold sensing electrode underneath the 1
cultured cell layer and calculates arbitrary cell index (CI) units, which are affected by the number, shape, 2
adhesion, and/or mobility of the adherent cells. The CI value of IM-BAT cells significantly dropped after 3
the incubation with differentiation medium I (Fig. 3A), as previously reported by Kramer AH et al. for 4
differentiation of 3T3-L1 cells (27). Interestingly, the CI curves of IM-BAT cells rapidly increased 5
followed by a slightly decrease after incubation with differentiation medium II. Furthermore, both acetate 6
and 4-CMTB treatment during the incubation with differentiation medium II dramatically decreased the 7
rise of CI compared to control. Cell death was ruled out as a cause for this decrease of CI values since cell 8
viability was confirmed by MTS assay (Fig.3B), indicating that the cell shape or adhesion instead of the 9
cell number contributes more to the difference of CI values.  10
Activation of GPR43 during differentiation of IM-BAT increased mitochondrial biogenesis in 11
brown adipocytes 12
Mitochondrial biogenesis has been associated with brown adipocyte differentiation and thermogenesis. 13
PGC-ĮLVDNH\FR-activator to turn on this process in brown adipocytes. Thus, we examined the effects 14
of acetate treatment on mitochondrial biogenesis in brown adipocytes. As shown in Fig.4A and B, the 15
mitochondrial DNA to nuclear DNA ratio was increased after IM-BAT cells treated with acetate or 4-16
CMTB during the differentiation period from day 2 until day 7. In agreement with this result, the flow 17
cytometry assay also documented increased mitochondrial mass in brown adipocytes after acetate 18
treatment during differentiation (Fig.4C). Furthermore, the basal oxygen consumption rate (OCR) and 19
spare respiratory capacity (stimulated by FCCP) in acetate treated cells were increased by 17%, and 24%, 20
respectively (Fig.4D). More pronounced increases of the basal OCR and reserve respiratory capacity were 21
also observed after 4-CMTB treatment during the differentiation of IM-BAT cells (Fig.4E). The IM-BAT 22
FHOOVGLIIHUHQWLDWHGZLWKDFHWDWH WUHDWPHQWDOVRVKRZLQFUHDVHG2&5XSRQȕ-adrenergic receptor agonist 23
CL316,243 treatment (Supplementary Fig.3).  These observed mitochondrial responses might also reflect 24
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increased mitochondria mass. These data consistently support the role of acetate activity in promoting 1
mitochondrial biogenesis. 2
Activation of GPR43 activate ERK1/2 and CREB in differentiated brown adipocytes 3
To determine the signalling pathways activated following acetate exposure in brown adipocytes, 4
Proteome Profiler phospho-kinase array spotted with antibodies against 43 different kinases and 2 related 5
total proteins (R&D Systems) was utilized. As shown in Fig.5A, the phosphorylation of ERK1/2 and 6
CREB (S133) increased by ~2.0 fold and ~2.6 fold vs. untreated cells, respectively, after 10 mM acetate 7
treatment for 10 min in differentiated brown adipocytes, suggesting increased activation of these two 8
kinases by acetate. To further determine the time course of ERK1/2 phosphorylation and CREB activation 9
in IM-BAT cells after acetate stimulation, cells were treated with 10 mM acetate from 5 to 60 min. This 10
experiment revealed that acetate increased p-ERK1/2 within 5 min and sustained a high level for 30 min 11
(Fig.5B). Furthermore, we also observed that CREB phosphorylation increased starting from 5 min and 12
stayed at peaking level at 10 min (Fig.5B). Similarly, 4-CMTB treatment also elicits the phosphorylation 13
of ERK1/2 and CREB in brown adipocytes (Fig.5C). It is well-established that activation of CREB 14
enhances PGC-Į H[SUHVVLRQ LQ D &5(%-dependent manner (28). Therefore, these data consistently 15
suggest that ERK1/2 and CREB were activated by acetate and that their activation may contribute to the 16
increase in PGC-ĮDFWLYLW\17
GPR43 knock-down impaired the effects of acetate or 4-CMTB on brown adipocytes 18
To further assess the role of GPR43 in acetate-induced effects on brown adipocytes, we transfected IM-19
BAT cells with GPR43 shRNA and selected with puromycin. Using shRNA for GPR43, we successfully 20
decreased gene expression to less than 30% of its baseline value in differentiated adipocytes (Fig.6A). We 21
examined the effects of acetate treatment on mitochondrial biogenesis in IM-BAT with impaired GPR43 22
expression (sh-GPR43-1) adipocytes. While the stimulatory effect of acetate on UCP1 mRNA was 23
apparent in control cells, this effect was impaired in cells transfected with shRNA for GPR43 (Fig.6B). 24
The stimulatory effect of acetate treatment on mitochondrial content was also significantly reduced in sh-25
16 
 
GPR43-1 adipocytes (Fig. 6C). Similarly, although acetate increased ERK1/2 and CREB phosphorylation, 1
there was no such stimulation in cells in which the GPR43 gene had been knocked-down (Fig.6D). These 2
results consistently support the hypothesis that GPR43, and not GPR41, is mainly involved in acetate-3
mediated effects in IM-BAT cells. 4
ERK1/2 activation is required for SCFA-induced CREB phosphorylation 5
Several studies have demonstrated that ERK1/2 is located upstream of CREB (29,30). Having defined 6
both ERK1/2 and CREB phosphorylation as a consequence of acetate treatment, we sought next to 7
elucidate whether ERK1/2 activation is required for SCFA evoked CREB phosphorylation. For this 8
purpose, the MEK1/2 inhibitor U0126 was used to block the phosphorylation of ERK1/2. As shown in 9
Fig.7A, although treatment of brown adipocytes with acetate caused the expected increase in ERK and 10
CREB phosphorylation, acetate was unable to induce CREB phosphorylation in cells pre-treated with 11
U0126, while ERK phosphorylation was almost completely abolished. These results indicate that ERK1/2 12
is a major mediator of SCFA-induced CREB phosphorylation. 13
Phosphorylation of ERK and CREB is dependent of the G(i/o)ȕȖ3/&3.&0(.VLJQDOOLQJSDWKZD\14
Previous research has demonstrated that GPR43 couples to both Gq and Gi proteins, which interact with 15
several downstream molecules (including adenylate cyclase, and phospholipase C) (31). As shown in 16
Fig.7B, pre-treatment with pertussis toxin (PTX), a Gi/o-type G protein inactivator, significantly attenuates 17
both ERK1/2 and CREB phosphorylation induced by acetate. It is reported that Gi/o mediates the PLC-18
PKC-(5.SDWKZD\YLDLWVȕȖVXEXQLWV(32). Therefore, we also examined the effects of pre-treatment 19
with Gallein (G(i/o)ȕȖ LQKLELWRU DQG 8 3/& LQKLELWRU RQ DFHWDWH-induced ERK and CREB 20
activation. Our results show that acetate-induced CREB activation was effectively blocked by these 21
inhibitors (Fig.7C & D7DNHQWRJHWKHUWKHVHUHVXOWVVXJJHVWWKDWWKH*LRȕȖ3/C/PKC pathway plays 22
a crucial role in acetate induced ERK and CREB activation. 23
24
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Discussion 1
Short-chain fatty acids are considered important energy sources, especially for colonocytes. Recent 2
evidence further revealed that short-chain fatty acids also mediate a spectrum of physiological functions 3
as signalling molecules (33). Several studies have established strong links between short-chain fatty acids 4
and energy metabolism. Accordingly, Ikuo Kimura et al. reported that short-chain fatty acids increase 5
energy expenditure in both the liver and muscle in mice (34). Another in vivo study in mice also found 6
that dietary supplementation of propionic acid and butyric acid protects against high fat diet-induced 7
obesity via inhibiting food intake, improving insulin sensitivity and increasing energy expenditure (35). 8
Additional studies also show that acetate reduces appetite via regulating neuropeptides which favour 9
appetite suppression (7). These findings suggest that short-chain fatty acids, through activation of their 10
receptors, regulate important signalling pathways involved in energy expenditure and homoeostasis. The 11
present study demonstrates that acetate stimulates mitochondrial biogenesis with up-regulation RI33$5Ȗ12
PGC-ĮDQG8&3H[SUHVVLRQLQEURZQDGLSRF\WHVVXJJHVWLQJWKDWVKRUW-chain fatty acids could function 13
as regulators of adipogenesis in brown adipocytes development and differentiation. Our results provide 14
novel insight to understand the regulatory effects of short-chain fatty acids in energy metabolism.  15
16
33$5ȖKDVEHHQVKRZQWREHFULWLFDOIRUDGLSRJHQHVLVLQYDULRXVDGLSRF\WHPRGHOVKRZHYHULWGRHVQRW17
induce adipogenesis alone (36). PGC-Į D WUDQVFULSWLRQFR-activator, is a key molecule that stimulates 18
EURZQDGLSRF\WHVGLIIHUHQWLDWLRQDQGLQWHUDFWVZLWK33$5ȖDQGGLUHFWJHQHWUDQVFULSWLRQLQYROYHGLQERWK19
adipogenesis and mitochondrial biogenesis (37). Increased PGC-ĮHQKDQFHVWKHWUDQVFULSWLRQRI15)-1 20
and NRF-2, leading to increased expression of mtTFA (15), as well as other nuclear-encoded 21
mitochondria subunits of the electron transport chain complex (e.g. ȕ-ATP synthase, cytochrome c, and 22
cytochrome c oxidase IV) (38). mtTFA translocates to the mitochondrion and stimulates mitochondrial 23
DNA replication and gene expression (39). PGC-ĮDOVRLQWHUDFWVZLWK33$5ȖRURWKHUQXFOHDUKRUPRQH24
receptors in BAT to up-regulate the expression of brown fat-specific UCP1 (40,41). Our results show that 25
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increased PGC-Į H[SUHVVLRQ DV ZHOO DV LQFUHDVHG PLWRFKRQGULDO PDVV DQG 8&3 H[SUHVVLRQ ZHUH1
observed after acetate treatment in brown adipocytes, suggesting the importance of PGC-Į LQ EURZn2
adipocyte differentiation. However, our findings are speculative that dietary supplementation of acetate 3
could potentially promote BAT by increasing the amount and/or activity of PGC-Į, thus offering an 4
additional target for the treatment of obesity and related metabolic diseases.  Further studies are needed to 5
determine whether acetate actions on UCP1 or mitochondrial biogenesis are PGC-Įmediated. Moreover, 6
additional studies are also required to delineate the potential effects of other short chain fatty acids, such 7
as butyrate and propionate, on brown adipose tissue.8
9
Furthermore, Kramer AH et al. have shown that the morphological changes during 3T3-L1 differentiation 10
could be monitored by the xCELLigence system (27). Treatment with a similar differentiation cocktail 11
(containing insulin, IBMX, Dexamethasone, and Rosiglitazone) leads to a rapid drop of the CI curve of 12
3T3-L1 cells (27), which seems to be necessary for successful differentiation of 3T3-L1 adipocytes. In 13
this study, a similar CI curve was also observed after the treatment of IM-BAT cells with differentiation 14
medium I containing insulin, IBMX, Dexamethasone, and T3. Kramer AH et al. have further established 15
that among the components of the full differentiation cocktail, treatment with IBMX only resulted in a CI16
profile similar to the one after treatment with the full differentiation cocktail, indicating that IBMX 17
mainly mediate the CI change of 3T3-L1 during the differentiation (27). Our findings are also in accord 18
with this finding, since an increased CI value was observed after the incubation with differentiation 19
medium II, which does not contain IBMX. In addition, our results also demonstrated that acetate 20
treatment could maintain the CI value at a lower level compared to normal differentiation control cells. 21
Based on the previous data from 3T3-L1 cells, documenting that the most efficient differentiation caused 22
by the full differentiation cocktail results in the most decreased CI value, our results indicate that the 23
decreased CI value might reflect promotive effects of acetate on the differentiation of IM-BAT cells. 24
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These results suggest that IM-BAT cells undergo morphological shifts during the differentiation and 1
activation of GPR43 could affect this process. 2
Moreover, our results further identified ERK/CREB signalling pathways in the underlying mechanism by 3
which GPR43 receptors regulate this response. GPR43 shares 38% identity with GPR41 in amino acid 4
sequence and recognizes short-chain fatty acids (42). Based on our experiments, we could not observe 5
GPR41 expression at detectable levels in brown adipocytes. This finding is consistent with previous data 6
reporting that nearly all identified physiological functions of short-chain fatty acids in white adipocytes 7
were mediated by GPR43. Notably, Choi SH et al. reported that co-culture of adipocytes with myoblasts 8
SURPRWHV &(%3ȕ DQG 33$5Ȗ JHQH H[SUHVVLRQ LQ GLIIHUHQWLDWHG P\REODVWV DQG *35 H[SUHVVLRQ LQ9
DGLSRF\WHVDOVRVXJJHVWLQJWKDW*35PLJKWEHLQYROYHGLQDGLSRJHQHVLVYLDPHGLDWLQJ33$5ȖDFWLYLW\10
(43). 11
12
Previous data have also reSRUWHG WKDW *LRȕȖ PHGLDWHV WKH 3/&-PKC-ERK signalling pathway. Our 13
ILQGLQJVLQGLFDWHWKDWWKLV*LRȕȖPHGLDWHG3/&-PKC-ERK signalling pathway is necessary for acetate 14
induced CREB phosphorylation. It has been well-studied that phosphorylation of CREB leads to 15
increased PGC-ĮH[SUHVVLRQLQD&5(%-dependent manner (28). Therefore, our data consistently suggest 16
that ERK1/2 and CREB activation may be the underlying mechanism of the increase in PGC-Į17
18
It is noteworthy that both GPR43-dependent and -independent mechanisms have been shown to mediate 19
pro-adipogenic effects of short-chain fatty acids on different adipose tissues. For example, short-chain 20
fatty acids have been reported to promote adipogenesis via inhibiting histone deacetylases (44), whilst the 21
conversion of acetate to acetyl-CoA also plays a role in lipid synthesis and energy generation. Therefore, 22
GPR43-independent mechanisms may also be mediating short-chain fatty acid-induced effects in brown 23
adipose tissue.  24
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Finally, we employed a purely classical infrascapular brown adipose tissue precursors system for our 1
experiments. A limitation in the present study was the lack of access to a My5- "beige" precursor line 2
which would have provided a more translational impact to our observations. Indeed, Jun Wu et al.3
suggested that there are two distinct types of brown fat: classical brown fat derived from a myf-5 cellular 4
lineage and UCP1-positive cells that emerge in white fat from a non-myf-5 lineage (45). These authors 5
FORQHG³EHLJH´FHOOs from murine white fat depots which respond to cyclic AMP stimulation with high 6
UCP1 expression and respiration rates. In the context of our study in order to establish that the observed 7
effects are not cell line dependent, we also performed experiments using an additional brown adipocyte 8
model (T37i) in which we alVR GRFXPHQWHG LQFUHDVHG 3*&Į DQG 8&3 H[SUHVVLRQ XSRQ DFHWDWH9
stimulation (Supplementary Fig.4). 10
11
In conclusion, the present study suggests that short-chain fatty acids play an important role in BAT 12
differentiation. Further studies are required to clarify the mechanisms of action of short-chain fatty acids 13
in adipogenesis of brown adipocytes. 14
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Acknowledgments 16
H S R acknowledges funding support from the General Charities of the City of Coventry and is grateful to 17
Dr Mark Christian, University of Warwick, for providing the IM-BAT cell line; and to Prof. Bo Bai, 18
Jining University, for providing assistance for the animal experiments.19
20
21 
 
References 1
1. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short 2
chain fatty acids. Journal of clinical gastroenterology 2006; 40:235-243 3
2. Tollinger CD, Vreman HJ, Weiner MW. Measurement of acetate in human blood by gas 4
chromatography: effects of sample preparation, feeding, and various diseases. Clinical chemistry 5
1979; 25:1787-1790 6
3. Pomare EW, Branch WJ, Cummings JH. Carbohydrate fermentation in the human colon and its 7
relation to acetate concentrations in venous blood. J Clin Invest 1985; 75:1448-1454 8
4. Scheppach W, Pomare EW, Elia M, Cummings JH. The contribution of the large intestine to blood 9
acetate in man. Clin Sci (Lond) 1991; 80:177-182 10
5. Peters SG, Pomare EW, Fisher CA. Portal and peripheral blood short chain fatty acid 11
concentrations after caecal lactulose instillation at surgery. Gut 1992; 33:1249-1252 12
6. Wolever TM, Josse RG, Leiter LA, Chiasson JL. Time of day and glucose tolerance status affect 13
serum short-chain fatty acid concentrations in humans. Metabolism 1997; 46:805-811 14
7. Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, 15
Hankir M, Zhang S, Carling D, Swann JR, Gibson G, Viardot A, Morrison D, Louise Thomas E, Bell 16
JD. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. 17
Nat Commun 2014; 5:3611 18
8. Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, 19
Rehmann A, Franke A, Ott S, Hasler R, Nikolaus S, Folsch UR, Rose-John S, Jiang HP, Li J, 20
Schreiber S, Rosenstiel P. G protein-coupled receptor 43 is essential for neutrophil recruitment 21
during intestinal inflammation. Journal of immunology 2009; 183:7514-7522 22
9. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, 23
Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via 24
the G-protein-coupled receptor FFAR2. Diabetes 2012; 61:364-371 25
10. Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, 26
Frost G. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty 27
acid receptor 2 in rodents. International journal of obesity 2014;  28
11. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. Activation of G protein-29
coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free 30
fatty acids. Endocrinology 2008; 149:4519-4526 31
12. Hong Y-H, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi K-C, Feng DD, Chen C, 32
Lee H-G, Katoh K, Roh S-G, Sasaki S. Acetate and Propionate Short Chain Fatty Acids Stimulate 33
Adipogenesis via GPCR43. Endocrinology 2005; 146:5092-5099 34
13. den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, Muller M, Groen AK, 35
Hooiveld GJ, Bakker BM, Reijngoud DJ. Gut-derived short-chain fatty acids are vividly assimilated 36
into host carbohydrates and lipids. American journal of physiology Gastrointestinal and liver 37
physiology 2013; 305:G900-910 38
14. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, 39
Doria A, Kolodny GM, Kahn CR. Identification and importance of brown adipose tissue in adult 40
humans. The New England journal of medicine 2009; 360:1509-1517 41
15. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, 42
Scarpulla RC. Mechanisms controlling mitochondrial biogenesis and respiration through the 43
thermogenic coactivator PGC-1. Cell 1999; 98:115-124 44
16. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical 45
management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and 46
22 
 
adjustment of therapy: a consensus statement of the American Diabetes Association and the 1
European Association for the Study of Diabetes. Diabetes Care 2009; 32:193-203 2
17. Belcher G, Matthews DR. Safety and tolerability of pioglitazone. Exp Clin Endocrinol Diabetes 3
2000; 108:267-273 4
18. Tuteja N. Signaling through G protein coupled receptors. Plant Signaling & Behavior 2014; 4:942-5
947 6
19. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth 7
MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall 8
FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. The Orphan G protein-9
coupled receptors GPR41 and GPR43 are activated by propionate and other short chain 10
carboxylic acids. The Journal of biological chemistry 2003; 278:11312-11319 11
20. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart 12
G, Van Damme J, Parmentier M, Detheux M. Functional characterization of human receptors for 13
short chain fatty acids and their role in polymorphonuclear cell activation. The Journal of 14
biological chemistry 2003; 278:25481-25489 15
21. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, 16
expressed on leukocytes and activated by short-chain fatty acids. Biochemical and biophysical 17
research communications 2003; 303:1047-1052 18
22. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis 19
D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota 20
and chemoattractant receptor GPR43. Nature 2009; 461:1282-1286 21
23. Vinolo MAR, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly-Y M, Stephens L, 22
Hawkins PT, Curi R. SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor. 23
PLoS ONE 2011; 6:e21205 24
24. Rosell M, Kaforou M, Frontini A, Okolo A, Chan YW, Nikolopoulou E, Millership S, Fenech ME, 25
MacIntyre D, Turner JO, Moore JD, Blackburn E, Gullick WJ, Cinti S, Montana G, Parker MG, 26
Christian M. Brown and white adipose tissues: intrinsic differences in gene expression and 27
response to cold exposure in mice. American journal of physiology Endocrinology and 28
metabolism 2014; 306:E945-964 29
25. ĂŝďŝD^͕^ƚŽĐŬĞƌ:͕K͛ŽǁĚ:͕ĂǀŝĞƐ͕ĞůůĂŚĐĞŶĞD͕ĂǁƚŚŽƌŶĞD͕ƌŽǁŶ:,͕^ŵŝƚŚD͕30
Arch JRS. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short 31
chain fatty acids. FEBS Letters 2010; 584:2381-2386 32
26. Smith NJ, Ward RJ, Stoddart LA, Hudson BD, Kostenis E, Ulven T, Morris JC, Tränkle C, Tikhonova 33
IG, Adams DR, Milligan G. Extracellular Loop 2 of the Free Fatty Acid Receptor 2 Mediates 34
Allosterism of a Phenylacetamide Ago-Allosteric Modulator. Molecular Pharmacology 2011; 35
80:163-173 36
27. Kramer AH, Joos-Vandewalle J, Edkins AL, Frost CL, Prinsloo E. Real-time monitoring of 3T3-L1 37
preadipocyte differentiation using a commercially available electric cell-substrate impedance 38
sensor system. Biochemical and Biophysical Research Communications 2014; 443:1245-1250 39
28. Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, Williams RS. Regulation 40
of mitochondrial biogenesis in skeletal muscle by CaMK. Science 2002; 296:349-352 41
29. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK Pathway to Gene Activation by 42
RSK2, a Growth Factor-Regulated CREB Kinase. Science 1996; 273:959-963 43
30. Impey S, Obrietan K, Wong ST, Poser S, Yano S, Wayman G, Deloulme JC, Chan G, Storm DR. 44
Cross Talk between ERK and PKA Is Required for Ca2+ Stimulation of CREB-Dependent 45
Transcription and ERK Nuclear Translocation. Neuron 1998; 21:869-883 46
23 
 
31. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth 1
MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall 2
FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. The Orphan G Protein-3
coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain 4
Carboxylic Acids. Journal of Biological Chemistry 2003; 278:11312-11319 5
32. Zhou Q, Li G, Deng XY, He XB, Chen LJ, Wu C, Shi Y, Wu KP, Mei LJ, Lu JX, Zhou NM. Activated 6
human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-7
dependent PKC and MMP-mediated EGFR pathways. British Journal of Pharmacology 2012; 8
166:1756-1773 9
33. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-10
chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. 11
Journal of Lipid Research 2013; 54:2325-2340 12
34. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, 13
Tani T, Takahashi T, Miyauchi S, Shioi G, Inoue H, Tsujimoto G. The gut microbiota suppresses 14
insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 15
2013; 4:1829 16
35. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate Improves Insulin 17
Sensitivity and Increases Energy Expenditure in Mice. Diabetes 2009; 58:1509-1517 18
36. Bastie C, Holst D, Gaillard D, Jehl-Pietri C, Grimaldi PA. Expression of Peroxisome Proliferator-19
ĂĐƚŝǀĂƚĞĚZĞĐĞƉƚŽƌWWZɷWƌŽŵŽƚĞƐ/ŶĚƵĐƚŝŽŶŽĨWWZɶĂŶĚĚŝƉŽĐǇƚĞŝĨĨĞƌĞŶƚŝĂƚŝŽŶŝŶϯdϯϮ20
Fibroblasts. Journal of Biological Chemistry 1999; 274:21920-21925 21
37. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator 22
of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92:829-839 23
38. Scarpulla RC. Transcriptional activators and coactivators in the nuclear control of mitochondrial 24
function in mammalian cells. Gene 2002; 286:81-89 25
39. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Barsh GS, Clayton DA. 26
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in 27
mice. Nature genetics 1998; 18:231-236 28
40. Barbera MJ, Schluter A, Pedraza N, Iglesias R, Villarroya F, Giralt M. Peroxisome proliferator-29
activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A 30
link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. 31
The Journal of biological chemistry 2001; 276:1486-1493 32
41. Cassard-Doulcier AM, Larose M, Matamala JC, Champigny O, Bouillaud F, Ricquier D. In vitro 33
interactions between nuclear proteins and uncoupling protein gene promoter reveal several 34
putative transactivating factors including Ets1, retinoid X receptor, thyroid hormone receptor, 35
and a CACCC box-binding protein. The Journal of biological chemistry 1994; 269:24335-24342 36
42. Sawzdargo M, George SR, Nguyen T, Xu S, Kolakowski Jr LF, O'Dowd BF. A Cluster of Four Novel 37
Human G Protein-Coupled Receptor Genes Occurring in Close Proximity to CD22 Gene on 38
Chromosome 19q13.1. Biochemical and Biophysical Research Communications 1997; 239:543-39
547 40
43. Choi SH, Chung KY, Johnson BJ, Go GW, Kim KH, Choi CW, Smith SB. Co-culture of bovine muscle 41
satellite cells with preadipocytes increases WWZɶĂŶĚͬWɴŐĞŶĞĞǆƉƌĞƐƐŝŽŶŝŶĚŝĨĨĞƌĞŶƚŝĂƚĞĚ42
myoblasts and increases GPR43 gene expression in adipocytes. The Journal of nutritional 43
biochemistry 2013; 24:539-543 44
44. Li G, Yao W, Jiang H. Short-chain fatty acids enhance adipocyte differentiation in the stromal 45
vascular fraction of porcine adipose tissue. J Nutr 2014; 144:1887-1895 46
24 
 
45. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, 1
Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerback S, Schrauwen P, 2
Spiegelman BM. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and 3
human. Cell 2012; 150:366-376 4
5
6
25 
 
FIGURE LEGENDS1
Fig.1 (A) GPR43 mRNA expression was identified by real-time PCR from cDNA pool of brown adipose 2
tissue (BAT). The minus-reverse transcriptase (minus-RT) control was introduced to exclude potential 3
genomic DNA contamination. (B) The mRNA transcription levels of GPR43 increase in the course of 4
adipogenesis of IM-BAT adipocytes. (C) Western blot analysis showing GPR43 expression in 5
undifferentiated and differentiated IM-BAT cells. (D) Immunohistochemistry analysis showing GPR43 6
expression in brown adipose tissue. Data are presented as mean ± S.E.M.. *P <0.05, **P<0.01 compared 7
to Day 0 by one-way ANOVA followed by Post-Hoc tests. 8
9
Fig.2. (A) IM-BAT cells were differentiated with or without acetate (10 mM) for 7 days and stained by 10
Oil Red O. The Oil Red O was extracted and the absorbance was measured in a plate reader at 490 nm. (B 11
and C) Relative mRNA levels of brown adipocyte markers in IM-BAT cells treated with or without 12
acetate (B) or 4-CMTB (C) during differentiation. (D and E) PGC-ĮDQG8&3SURWHLQ OHYHOV LQ ,0-13
BAT cells treated with or without acetate (D) or 4-CMTB (E) during differentiation. (F) Effects of acetate 14
administration on PGC-ĮDQG8&3H[SUHVVLRQLQLQWHUVFDSXODU brown adipose tissue of C57BL/6J male 15
mice (n = 5 for control, n = 5 for acetate administration). (G) Effects of acute acetate treatment (6 h; 10 16
mM) on PGC-ĮDQG8&3H[SUHVVLRQLQGLIIHUHQWLDWHG,0-BAT cells. ȕ-adrenergic receptor agonist CL-17
316,243 (CL) was used as positive control. Data are presented as mean ± S.E.M.. *P <0.05, **P<0.01, 18
3E\VWXGHQW¶VW-test compared with no acetate treated controls. 19
20
Fig.3 (A) Effects of acetate on immortalized BAT (IM-BAT) cell growth CI curves during differentiation. 21
IM-BAT cells were treated with differential medium I followed by Insulin + T3 (top); or Insulin + T3 + 22
Acetate (middle); or Insulin + T3 + 4-CMTB (bottom) at the same time to compare the resulting CI23
growth curves. All curves were plotted as the average of quadruplicate treatments, with error bars shown 24
as S.E.M. (n = 4). Compared to Insulin + T3, the Insulin + T3 + Acetate and the Insulin + T3 + 4-CMTB 25
26 
 
arms of the experiment showed much lower CI values. (B) Cell viability of IM-BAT cells after 1
differentiation was measured by the MTS assay. Values presented as mean ± S.E.M..  ns = non-significant 2
to control group. 3
4
Fig.4 (A & B) Relative mitochondrial DNA levels in immortalized BAT (IM-BAT) cells treated with or 5
without acetate (A) or 4-CMTB (B) during differentiation from day 2 until day 7 post-induction. (C) 6
Mitochondrial mass of IM-BAT cells, treated with acetate during differentiation from day 2 until day 7 7
post-induction, was measured by flow cytometry and compared with untreated cells by fluorescence 8
levels upon staining with CytoPainter MitoNIR Indicator Reagent. (D & E) The effect of acetate (D) or 4-9
CMTB (E) treatment on mitochondrial respiratory capacity of IM-BAT during differentiation measured 10
by the XF24 analyzer. Group mean oxygen consumption rate (OCR) in pMol/min/μg protein of IM-BAT 11
cells treated with or without acetate at 10 mM during differentiation from day 2 to day 7. Vertical lines 12
LQGLFDWHWLPHRIDGGLWLRQRIPLWRFKRQGULDO LQKLELWRUVDROLJRP\FLQȝ0E)&&3ȝ0RU F13
DQWLP\FLQ$ȝ0	URWHQRQHȝ0%DVal OCR, maximum OCR, spare capacity of cells treated as 14
described above. Values presented as mean ± S.E.M.. * P <0.05 E\VWXGHQW¶VW-test.   15
16
Fig.5 (A) Immortalized BAT (IM-BAT) cells were differentiated for 5 days and either left untreated or 17
treated with acetate for 10 minutes. Site-specific phosphorylation of 43 kinases were analysed by R&D 18
Proteome Profiler Phospho-Kinase Array Kit. (B) Time-course of ERK and CREB activation following 19
treatment with acetate in IM-BAT cells. Differentiated IM-BAT cells were either left untreated or treated 20
with acetate for 5, 10, 15, 30 and 60 minutes. (C) Time-course of ERK and CREB activation following 21
treatment with 4-CMTB in IM-BAT cells. Differentiated IM-BAT adipocytes were either left untreated or 22
treated with 4-CMTB for 5, 10, 15, 30 and 60 minutes. Data are presented as mean ± S.E.M.. *P <0.05, 23
**P<0.01, ***P<0.001, compared to time 0 minutes by one-way ANOVA followed by Post-Hoc tests (B 24
and C). 25
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Fig.6 (A) Validation of shRNA-mediated knockdown of GPR43. Undifferentiated immortalized BAT 1
(IM-BAT) cells were transfected with shRNA non-targeting control (#RHS6848) or shRNA targeting 2
GPR43 (sh-GPR43-1: TRCN0000027581; sh-GPR43-2: TRCN0000027541; sh-GPR43-3: 3
TRCN0000027562; sh-GPR43-4: TRCN0000027552). Following selection by puromycin, cells were 4
lysed with Qiazol after 7 days of differentiation and subjected to real-time PCR analysis. Data are 5
presented as mean ± S.E.M, with significant differences compared to mock control, **P<0.01, 6
***P<0.001 as analysed by one-way ANOVA followed by Post-Hoc tests. (B & C) IM-BATs transfected 7
with non-targeting shRNA control or shRNA targeting GPR43 were treated with or without acetate 8
during differentiation. Relative mRNA levels of UCP1 (B) and relative mitochondrial DNA (mtDNA) 9
levels (C) were analysed by real-time PCR, where silencing the GPR43 receptor showed no change in 10
UCP-1 or mtDNA expression. Data are presented as mean ± S.E.M.. *P <0.05 compared to no acetate 11
treated FRQWUROVE\ VWXGHQW¶V W-test. (D) Time-course of ERK and CREB activation following treatment 12
with acetate in IM-BAT cells expressing GRP43 shRNA. Puromycin selected IM-BAT cells with GPR43 13
shRNA were differentiated for 5 days and either left untreated or treated with Acetate (10 mM) for 5, 10, 14
15, 30 and 60 minutes. Data are presented as mean ± S.E.M.. 15
16
Fig.7 (A) Effects of U0126 on acetate-induced ERK and CREB phosphorylation. (B) Effects of pertussis 17
toxin (PTX) on acetate-induced ERK and CREB phosphorylation. (C) Effects of Gallein on acetate-18
induced ERK and CREB phosphorylation. (D) Effects of U73122 on acetate-induced ERK and CREB 19
phosphorylation. In all experiments, immortalized BAT (IM-BAT) cells were differentiated for 5 days 20
and stimulated with acetate (10 mM) for 15 min after pre-treatment with U0126 (10 μM), PTX (1 μg ml-1),21
Gallein (10 μM), or U73122 (1 μM) for 3h. Data are presented as mean ± S.E.M.. *P <0.05, **P<0.01, 22
***P<0.001 compared by one-way ANOVA followed by Post-Hoc tests. 23
24
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Supplementary Figure 1 1
Identification of immortalized BAT (IM-BAT) cells as a brown adipocyte model in vitro. (A) 2
Macroscopic pictures of Oil Red-O staining of immortalized BAT (IM-BAT) cells differentiated for 7 3
days. (B) Expression levels of UCP1 mRNA in the course of adipogenesis of IM-BAT cells. IM-BAT 4
cells were differentiated and cell lysate were collected at day 0, day 3, day 6 and day 9.  Transcription of 5
UCP-1 was detected by real-time PCR. (C) UCP-1 and mitochondrial DNA levels in differentiated IM-6
BAT cells and differentiated 3T3-L1 cells. IM-BAT and 3T3-L1 cells were differentiated; total RNA and 7
WRWDO'1$ZDVLVRODWHGE\*HQ(OXWH0DPPDOLDQ7RWDO51$0LQLSUHS.LWDQG4,$DPS'1$0LQLNLW8
respectively. UCP-1 transcription and mitochondrial DNA to genomic DNA ratio were measured by real-9
time PCR. (D) Effects of CL-316,243 (CL) treatment on expression levels of UCP1 in differentiated IM-10
BAT cells. IM-BAT cells were differentiated then treated with CL-316,243 (10 μM) for 6 h. Expression 11
of UCP1 was measured by real-time PCR. (E) Effects of CL-316,243 (CL) treatment on glucose uptake in 12
differentiated IM-BAT cells. IM-BAT cells were differentiated and starved in glucose-free, serum-free 13
DMEM:F12 medium for 3 h. The cells then were treated with CL-316,243 (10 μM) for 3 h and stained 14
with 2-NBDG (150 μg/ml). Fluorescence (ex/em = 465/540 nm) was measured by flow cytometry. (F) 15
Effects of insulin treatment on Akt activation in differentiated IM-BAT cells. IM-BAT cells were 16
differentiated and serum-starved overnight. The cells then were treated with insulin (1 μM) for 15 min. 17
The phosphorylated Akt and total Akt were measured by western blots. Data are presented as mean ± 18
S.E.M.. *P <0.05, **P<0.01, ***P<0.001. 19
20
Supplementary Figure 2 21
Concentration-dependent effects of acetate treatment on PGC-ĮDQG8&3GXULQJEURZQDGLSRJHQHVLV in 22
immortalized BAT (IM-BAT) cells. IM-BAT cells were differentiated for 7 days with or without acetate 23
at different concentrations (0.1 - 10 mM, from day 2 to day 7). The cells were lysed with QIAzol. The 24
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transcription levels of PGC-ĮDQG8&3ZHUHPHDVXUHGE\UHDO-time PCR. Data are presented as mean 1
6(0333FRPSDUHGWRFRQWUROE\VWXGHQW¶VW-tests. 2
3
Supplementary Figure 3 4
The effect of acetate treatment during differentiation on the mitochondrial respiratory capacity in 5
immortalized BAT (IM-%$7 FHOOV LQ UHVSRQVH WR ȕ-adrenergic stimulation. The x axis represents the 6
applied XF24 protocol measurements and the vertical line indicates the time of addition of CL316,234 7
(CL). Data are expressed as the percentage of the basal value measured at the time point 3 (four replicates) 8
in the control group. OCR: oxygen consumption rate. 9
10
Supplementary Figure 4 11
Relative mRNA levels of brown adipocyte markers in T37i cells treated with or without acetate during 12
differentiation. Data are presented as mean ± S.E.M.. *P <0.05, **P<0.01 E\VWXGHQW¶V W-test compared 13
with no acetate treated controls. 14
15
Table.1 Primer sequence  
Primer Sequence (5'-3') 
mGPR43-Forward CCACTGTATGGAGTGATCGCTG 
mGPR43-Reverse GGGTGAAGTTCTCGTAGCAGGT 
mBMP7-Forward GGAGCGATTTGACAACGAGACC 
mBMP7-Reverse AGTGGTTGCTGGTGGCTGTGAT 
mPRDM16-Forward ATGCGAGGTCTGCCACAAGT 
mPRDM16-Reverse CTGCCAGGCGTGTAATGGTT 
mPPARg-Forward GGCTTCCACTATGGAGTTCA 
mPPARg-Reverse GATCCGGCAGTTAAGATCAC 
mPGC1a-Forward TGCAGCCAAGACTCTGTATG 
mPGC1a-Reverse ATTGGTCGCTACACCACTTC 
mUCP1-Forward CACTCAGGATTGGCCTCTAC 
mUCP1-Reverse CTGACCTTCACGACCTCTGT 
mAP2-Forward ATCACCGCAGACGACAGGAA 
mAP2-Reverse TTCCACCACCAGCTTGTCAC 
mRPL19-Forward GGAAAAAGAAGGTCTGGTT 
mRPL19-Reverse TGATCTGCTGACGGGAGT 
m_mtDNA_D-loop_Forward AATCTACCATCCTCCGTG 
m_mtDNA_D-loop_Reverse GACTAATGATTCTTCACCGT 
m_18S_rDNA_Forward CATTCGAACGTCTGCCCTATC 
m_18S_rDNA_Reverse CCTGCTGCCTTCCTTGGA 
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Peptide/protein target Antigen sequence (if known) Name of Antibody
Manufacturer, catalog #, 
and/or name of individual 
providing the antibody
Species raised in; monoclonal or 
polyclonal Dilution used
phospho-Erk1/2 
(Thr202/Tyr204) 
Phospho-p44/42 
MAPK (Erk1/2)
(Thr202/Tyr204) 
Antibody #9101
Cell Signaling (#9101)  Rabbit, monoclonal 1:1500
Erk1/2 
p44/42 MAPK
(Erk1/2) (137F5)
Rabbit mAb #4695
Cell Signaling (#4695)  Rabbit , monoclonal 1:2000
phospho-CREB (Ser133) 
Phospho-CREB 
(Ser133) (87G3)
Rabbit mAb #9198
Cell Signaling (#9198)  Rabbit , monoclonal 1:1000
CREB
CREB (48H2)
Rabbit mAb #9197 Cell Signaling (#9197)  Rabbit , monoclonal 1:1000
UCP1
Anti-UCP-1 
antibody Sigma (U6382)  Rabbit,  polyclonal 1:1000
3*&Į
PGC-1 Antibody
(H-300): sc-13067 Santa Cruz (sc-13067)  Rabbit, polyclonal 1:1000
ȕ$FWLQ
ȕ$FWLQ Antibody
(C4): sc-47778 Santa Cruz (sc-47778)  Mouse, monoclonal 1:5000
$QWLERG\7DEOH




